Literature DB >> 10969356

Successful allogeneic bone marrow transplant in an HIV-1-positive man with chronic myelogenous leukemia.

P Schlegel, P Beatty, R Halvorsen, J McCune.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10969356     DOI： 10.1097/00126334-200007010-00017

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  9 in total

Review 1.  Risks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.

Authors:  Shukaib Arslan; Mark R Litzow; Nathan W Cummins; Stacey A Rizza; Andrew D Badley; Willis Navarro; Shahrukh K Hashmi
Journal:  Biol Blood Marrow Transplant       Date:  2019-03-26       Impact factor: 5.742

2.  Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; Mi Kwon; Gabriela Rodriguez-Macias; Jorge Gayoso; Javier Anguita; Ismael Buño; Juan Berenguer; José L Díez-Martín
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-24       Impact factor: 2.205

Review 3.  Novel cell and gene therapies for HIV.

Authors:  James A Hoxie; Carl H June
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

Review 4.  Hematopoietic stem cell transplantation in patients infected with HIV.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; José Luis Díez-Martin; Juan Berenguer
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 5.  Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years.

Authors:  G Hütter; J A Zaia
Journal:  Clin Exp Immunol       Date:  2011-03       Impact factor: 4.330

6.  Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.

Authors:  Vikas Gupta; Marcie Tomblyn; Tanya L Pedersen; Harry L Atkins; Minoo Battiwalla; Ronald E Gress; Marilyn S Pollack; Jan Storek; Jill C Thompson; Pierre Tiberghien; Jo-Anne H Young; Patricia Ribaud; Mary M Horowitz; Armand Keating
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

Review 7.  Blood and marrow transplant for lymphoma patients with HIV/AIDS.

Authors:  Nina D Wagner-Johnston; Richard F Ambinder
Journal:  Curr Opin Oncol       Date:  2008-03       Impact factor: 3.645

8.  Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART.

Authors:  Yoko Oka; Haruko Tashiro; Mitsuho Mizutani-Noguchi; Ichiro Koga; Toshihiko Sugao; Ryosuke Shirasaki; Toshiyuki Miura; Nobu Akiyama; Kazuo Kawasugi; Shin Fujimori; Naoki Shirafuji
Journal:  Int J Hematol       Date:  2009-12-25       Impact factor: 2.490

9.  Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.

Authors:  Lorena Vigón; Paula Martínez-Román; Sara Rodríguez-Mora; Montserrat Torres; María C Puertas; Elena Mateos; María Salgado; Antonio Navarro; Matilde Sánchez-Conde; Juan Ambrosioni; Miguel Cervero; Christoph Wyen; Christian Hoffmann; José M Miró; José Alcamí; Daniel Podzamczer; Valentín García-Gutiérrez; Javier Martínez-Picado; Verónica Briz; María Rosa López-Huertas; Vicente Planelles; Mayte Coiras
Journal:  Biochem Pharmacol       Date:  2021-06-26       Impact factor: 6.100
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.